10.11.2014 Views

OM t of c.iii - Vision Research Coordinating Center - Washington ...

OM t of c.iii - Vision Research Coordinating Center - Washington ...

OM t of c.iii - Vision Research Coordinating Center - Washington ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2/22/96 Chapter 3 Entry and Enrollment page 3-1<br />

3.1 Screening for Eligibility<br />

Chapter 3<br />

Entry and Enrollment<br />

Screening for CLEK Study eligibility is conducted on any patient who carries the<br />

working diagnosis <strong>of</strong> keratoconus or in whom keratoconus is a possible diagnosis.<br />

An Eligibility Form is completed by the Clinician on any keratoconus patient<br />

evaluated for CLEK Study eligibility at any visit to a Participating Clinic. Referring<br />

doctors can complete a draft Eligibility Form to evaluate a patient, but the Participating<br />

Clinic must complete its own Eligibility Form for submission to the <strong>Coordinating</strong><br />

<strong>Center</strong>. This will track non-eligible patients and eligible patients who decline to<br />

participate in the CLEK Study. The Eligibility Form is forwarded to the <strong>Coordinating</strong><br />

<strong>Center</strong>.<br />

3.2 Implementation <strong>of</strong> Eligibility Criteria<br />

Any patient carrying a working diagnosis <strong>of</strong> keratoconus is a CLEK Study<br />

candidate. Given the relative simplicity <strong>of</strong> a preliminary screening for the entry and<br />

exclusion criteria, patients can be quickly evaluated to determine whether it is worth the<br />

Study candidate’s and the Clinic’s time to schedule the Baseline Visit. The Clinician<br />

should complete the Eligibility Form on any patient carrying the working diagnosis <strong>of</strong><br />

keratoconus and should forward a copy <strong>of</strong> the form—whether the patient turns out to<br />

be eligible or not—to the <strong>Coordinating</strong> <strong>Center</strong>. If the patient appears eligible upon<br />

completion <strong>of</strong> the Eligibility Form, the Clinician explains the CLEK Study to the patient,<br />

requests that the patient sign an informed consent form, and schedules the patient for<br />

his or her Baseline Visit once the patient has provided informed consent.<br />

CLEK Participating Clinic personnel are informed at the beginning <strong>of</strong> the Study<br />

and at annual CLEK Study Group meetings that enrollment <strong>of</strong> an ineligible patient is a<br />

serious protocol error. The Participating Clinics will be reminded <strong>of</strong> the ramifications <strong>of</strong><br />

enrolling a patient who is later deemed ineligible. Corrective action will be taken<br />

against Clinics who repeatedly enroll ineligible patients.<br />

3.3 Inclusion Criteria<br />

If all <strong>of</strong> the following conditions are satisfied, the patient is eligible for the CLEK<br />

Study:<br />

• Age: At least 12 years old<br />

• Irregular corneal surface in either eye as determined by distortion <strong>of</strong> keratometric<br />

mires, <strong>of</strong> the retinoscopic reflex, or <strong>of</strong> the red reflex.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!